FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened

Key points:

FDA Layoffs Affect Tobacco Enforcement: The US Department of Health and Human Services (HHS) laid off approximately 10,000 employees on April 1, including the department responsible for fining retailers for violations under the FDA. This move may result in a slowdown in tobacco enforcement efforts.

FDA has requested that some laid-off employees temporarily return to work to help with unfinished cases. About 20 employees have agreed to return until their official departure on June 2nd.

Weakened regulatory ability: Layoffs have weakened the FDA's ability to enforce penalties on non-compliant retailers, experts worry this may undermine the recent decline in tobacco use rates.

Fines Income Affected: The disbandment of the Civil Fines Office could impact FDA's fines income, leading to a reduction in federal revenue. This office is also a key tool in cracking down on the illegal distribution of e-cigarettes.

Reasons for HHS Staff Reduction: The Department of Health and Human Services stated that the layoffs are primarily focused on administrative and redundant positions. However, FDA officials believe that this move severely undermines tobacco enforcement capabilities and could lead to looser retailer behavior.

According to a report from POLITICO on April 14th, the U.S. Food and Drug Administration (FDA) has recently asked some tobacco enforcement agents who were previously laid off to temporarily return to work in order to address the halt in regulatory capacity caused by significant manpower reductions.

According to four federal health officials, the layoffs were carried out by the Secretary of the Department of Health and Human Services (HHS), Robert F. Kennedy Jr., on April 1st, resulting in the dismissal of around 10,000 employees, including those responsible for imposing civil fines on non-compliant retailers at the FDA. This department was previously able to handle over a hundred cases of illegal sales per week, focusing on punishing stores that sell cigarettes and e-cigarettes to minors.

Informed officials have stated that the recent layoffs have crippled the FDA's main enforcement tool against tobacco retailers, leading to a halt in related case processing. In order to maintain enforcement continuity as much as possible, senior FDA officials recently invited some laid-off employees to return on a short-term basis to assist with processing before their formal departure date on June 2nd. As of last Friday, more than 20 people have agreed to return to work. It is reported that some employees are concerned that if they refuse to return, they may lose their severance package.

Kennedy's cost-cutting measures have not affected the team responsible for handling warning letters and comprehensive bans, but there is a lack of a team responsible for enforcing fines and sales bans. Former FDA Center for Tobacco Products Director Mitch Zeller stated that this move essentially allows retailers to "flout the law," severely undermining policies aimed at controlling youth tobacco use.

In 2024, the tobacco use rate among American teenagers hit a new low in 25 years, causing concern among health experts. They worry that without continued federal enforcement support, this achievement could face the risk of reversal. At the same time, the Civil Monetary Penalty Office is also a key tool in combating the illegal distribution of e-cigarettes.

Currently, it is not clear why the Department of Health and Human Services (HHS) is focusing on dismantling the office responsible for civil penalties, which is a part of the U.S. Food and Drug Administration's (FDA) tobacco enforcement system known as the Division of Business Operations. The entire operational costs of the FDA Center for Tobacco Products are covered by user fees paid by the industry, with no involvement of federal budgets. This means that layoffs will not result in any savings for taxpayers, but could potentially reduce the Treasury's revenue from fines imposed by the FDA.

After layoffs, the FDA has not yet announced its future plan for enforcement restructuring. According to internal sources, some senior officials at the FDA's Center for Tobacco Products are still trying to fully restore its functions, but some employees have been told that returning to work in the short term does not necessarily mean they will be rehired in the future.

Department of Health and Human Services spokesperson Andrew Nixon stated in a declaration that laid-off employees may be required to work for a short period before their official departure date (June 2nd), with the aim of "minimizing disruptions to agency functions and ensuring a smooth transition.

Kennedy stated in a previous interview with the media that all positions that were cut were either administrative or considered redundant. He emphasized that the relevant work would be taken over by other programs through integration. Internal officials at the FDA have stated that these cuts have effectively paralyzed their tobacco enforcement actions. The agency's enforcement process consists of three stages: first-time offenders receive a warning letter, repeated violations result in civil penalties, and the most serious violations lead to a ban on all tobacco sales.